Multiple Australian outlets report that global pharmaceutical companies marketing prescription weight-loss drugs are using advertising approaches that they say are intended to comply with Australian rules. The coverage focuses on campaigns associated with medicines such as Ozempic and Mounjaro, which contain active ingredients used for weight management and are available only with a prescription. Reported concerns centre on the ads’ messaging style: rather than promoting the drugs directly, the campaigns include general health or emotional-awareness themes and encourage people to “talk to your doctor.” The outlets state that prescription medicines are restricted in how they can be advertised in Australia, which bars spruiking prescription medication to the public. The articles argue that these companies’ communications may be designed to stay within the letter of the law while still steering consumers toward discussion of the drugs with clinicians. The reports do not indicate that the companies are breaching the rules directly, but they highlight ongoing scrutiny of how such campaigns operate under Australia’s advertising and medicines regulations.